Table 3.
Hazard ratios (95% CIs) of all-cause mortality associated with various levels of EF and with the presence of LVHa
| EF <30% N = 51 | EF 30–50% N = 194 | EF >50% (referent) N = 405 | P for trend | LVH N = 278 | No LVH (referent) N = 369 | P | |
| Model 0 | 2.57 (1.87–3.54) | 1.25 (1.02–1.53) | 1 | <0.001 | 0.86 (0.71–1.04) | 1 | 0.11 |
| Model 1 | 2.25 (1.57–3.23) | 1.16 (0.93–1.45) | 1 | <0.001 | 0.88 (0.71–1.07) | 1 | 0.2 |
| Model 2 | 2.62 (1.78–3.87) | 1.25 (0.99–1.57) | 1 | <0.001 | 0.80 (0.65–0.99) | 1 | 0.04 |
| Model 3 | 2.83 (1.86–4.30) | 1.38 (1.06–1.78) | 1 | <0.001 | 0.83 (0.66–1.05) | 1 | 0.12 |
a
Associations were examined in unadjusted Cox models (Model 0) and with adjustments for age, race, CAD, cerebrovascular disease, peripheral vascular disease, diabetes mellitus, malignancies, Charlson index, baseline medication use and smoking (Model 1), for Model 1 variables + estimated GFR, albumin, cholesterol, calcium, phosphorus, haemoglobin, WBC count, percent of lymphocytes in WBC count and 24 h urine-adjusted (Model 2) and for Model 2 variables + systolic and diastolic blood pressure.